Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after pancreatic surgery

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 19, Issue 4, 2012, Pages 492-500

  Warschkow, Rene ^a,b   Ukegjini, Kristjan ^a   Tarantino, Ignazio ^a   Steffen, Thomas ^a   Müller, Sascha A ^a   Schmied, Bruno M ^a   Marti, Lukas ^a  

^a Kantonsspital St Gallen ^*  (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

C reactive protein; Diagnostic study; Pancreatic surgery; Postoperative inflammatory complications

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL ABSCESS; ADULT; AREA UNDER THE CURVE; ARTICLE; CATHETER INFECTION; CHOLANGITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS FISTULA; PANCREAS SURGERY; PANCREATITIS; PNEUMONIA; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; WOUND INFECTION;

AGED; ANASTOMOTIC LEAK; AREA UNDER CURVE; C-REACTIVE PROTEIN; CATHETERIZATION, CENTRAL VENOUS; CHOLANGITIS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC DISEASES; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURGICAL WOUND INFECTION; URINARY TRACT INFECTIONS;

EID: 84867402531     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-011-0462-x     Document Type: Article

References (51)

1. Kausch W. Das Carcinom der papilla duodeni und seine radikale Entfernung. Beiträge zur Klinischen Chirurgie. 1912;78:439-86.
2. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg. 1935;102:763-79.
3. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987;206:358-65.
4. Kleespies A, Eichhorn M, Seeliger H, Jauch KW, Bruns CJ. Anastomotic complications in pancreatic surgery. Viszeralchirurgie. 2007;42:306-16.
5. Hill JS, Zhou Z, Simons JP, Ng SC, McDade TP, Whalen GF, et al. A simple risk score to predict in-hospital mortality after pancreatic resection for cancer. Ann Surg Oncol. 2010;17: 1802-7.
6. Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351:1218-26.
7. Spinelli P, Meroni E, Prada A. Endoscopic treatment of a pancreatic pseudocyst by naso-cystic tube. Endoscopy. 1988;20: 27-9.
8. Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy - are they all 'chronic pancreatitis'? Am J Surg Pathol. 2003;27:110-20.
9. Muller MW, Friess H, Martin DJ, Hinz U, Dahmen R, Buchler MW. Long-term follow-up of a randomized clinical trial comparing Beger with pylorus-preserving Whipple procedure for chronic pancreatitis. Br J Surg. 2008;95:350-6.
10. Orr RK. Outcomes in Pancreatic Cancer Surgery. Surg Clin N Am 2010;90:219-234.
11. Kawai M, Yamaue H. Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today. 2010;40:1011-7.
12. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248-57.
13. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138:1310-4.
14. Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. 2009;13:1798-805.
15. Pratt W, Maithel SK, Vanounou T, Callery MP, Vollmer CM Jr. Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy. J Gastrointest Surg. 2006;10:1264-78.
16. Balcom JH, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391-8.
17. Kwok KH, Rizk J, Coleman M, Fenton-Lee D. Pancreaticoduodenectomy - outcomes from an Australian institution. ANZ J Surg. 2010;80:605-8.
18. McKay A, Mackenzie S, Sutherland FR, Bathe OF, Doig C, Dort J, et al. Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg. 2006;93:929-36.
19. Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, et al. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg. 2007;193:171-83.
20. Beger HG, Gansauge F, Schwarz M, Poch B. Pancreatic head resection: the risk for local and systemic complications in 1315 patients - a monoinstitutional experience. Am J Surg. 2007;194:S16-9.
21. Su ZX, Koga R, Saiura A, Natori T, Yamaguchi T, Yamamoto J. Factors influencing infectious complications after pancreatoduodenectomy. J Hepato-Biliary-Pancreat Sci. 2010;17:174-9.
22. Yeo CJ. Pancreatic surgery 101 drain, no drain, early drain removal, or late drain removal. What are the data? Where do we go from here? Ann Surg. 2010;252:215-6.
23. Hackert T, Buchler MW, Werner J. Surgical options in the management of pancreatic cancer. Minerva Chirurgica. 2009;64:465-76.
24. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.
25. Puskarich MA, Marchick MR, Kline JA, Steuerwald MT, Jones AE. One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care. 2009;13:R167.
26. Rivers EP. Point: adherence to early goal-directed therapy: does it really matter? Yes. After a decade, the scientific proof speaks for itself. Chest. 2010;138:476-80.
27. Behrman SW, Zarzaur BL. Intra-abdominal sepsis following pancreatic resection: incidence, risk factors, diagnosis, microbiology, management, and outcome. Am Surg. 2008;74: 572-8.
28. Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F, et al. Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg. 2009;197:702-9.
29. Kawai M, Tani M, Hirono S, Ina S, Miyazawa M, Yamaue H. How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy? An analysis in 244 consecutive patients. World J Surg. 2009;33:2670-8.
30. Winter JM, Cameron JL, Yeo CJ, Alao B, Lillemoe KD, Campbell KA, et al. Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg. 2007;204:1029-36.
31. Mroczko B, Groblewska M, Gryko M, Kedra B, Szmitkowski M. Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J Clin Lab Anal. 2010;24:256-61.
32. Muller MW, Friess H, Koninger J, Martin D, Wente MN, Hinz U, et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg. 2008;195:221-8.
33. Tingstedt B, Johansson P, Andersson B, Andersson R. Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol. 2007;42:754-9.
34. Welsch T, Frommhold K, Hinz U, Weigand MA, Kleeff J, Friess H, et al. Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery. 2008;143:20-8.
35. Bianchi RA, Silva NA, Natal ML, Romero MC. Utility of base deficit, lactic acid, microalbuminuria, and C-reactive protein in the early detection of complications in the immediate postoperative evolution. Clin Biochem. 2004;37:404-7.
36. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006;10:R145.
37. Chromik AM, Endter F, Uhl W, Thiede A, Reith HB, Mittelkotter U. Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study. Langenbecks Arch Surg. 2006;391:187-94.
38. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206-17.
39. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-96.
40. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13.
41. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
42. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
43. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.
44. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Stat Sci. 1996;11:189-212.
45. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
46. Paul M, Riebler A, Bachmann LM, Rue H, Held L. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations. Stat Med. 2010;29:1325-39.
47. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996-2003.
48. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351:17-29.
49. Cicarelli DD, Vieira JE, Bensenor FE. C-reactive protein is not a useful indicator for infection in surgical intensive care units. Sao Paulo Med J. 2009;127:350-4.
50. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7:210-7.
51. Sackett DL, Haynes RB. The architecture of diagnostic research. BMJ. 2002;324:539-41.